Camber Announces Citalopram Tablet Size Change
Dear Valued Customer,
In accordance with Reference Listed Drug (RLD) guidelines, this letter is to inform you that Camber Pharmaceuticals/Invagen Pharmaceuticals has received FDA approval for an alternative quantitative formula for Citalopram Tablets, 10mg and 20mg.
The following change in tablet size will occur.
GENERIC NAME | STRENGTH | OLD TABLET SIZE | NEW TABLET SIZE |
CITALOPRAM | 10 mg | 9mm | 6mm |
CITALOPRAM | 20 mg | 9mm | 7mm |
Camber Pharmaceuticals appreciates your continued support and regrets any inconvenience this change may cause you.
Should you have any questions or concerns regarding this change, please contact your Camber Pharmaceuticals National Account Director.
Sincerely,
Kon Ostaficiuk
Kon Ostaficiuk
President
Camber Pharmaceuticals, Inc.
Recent articles
- Camber’s Parent Company, Hetero, Partners with the Gates Foundation to Supply Generic Lenacapavir for HIV Prevention
- Camber Adds 800 mg Darunavir Tablets to Product Family
- Camber Expands Portfolio with 10 New Generic Drug Launches in Q3 2025
- Camber Launches Indomethacin Suppositories
- Camber Launches Voriconazole for Injection
- Camber Launches Magnesium Sulfate Injection